These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16269137)

  • 41. LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential.
    Tao YM; Li QL; Zhang CF; Xu XJ; Chen J; Ju YW; Chi ZQ; Long YQ; Liu JG
    Eur J Pharmacol; 2008 Apr; 584(2-3):306-11. PubMed ID: 18353307
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chronic morphine treatment induces functional delta-opioid receptors in amygdala neurons that project to periaqueductal grey.
    Chieng B; Christie MJ
    Neuropharmacology; 2009 Sep; 57(4):430-7. PubMed ID: 19580818
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The roles of different subtypes of opioid receptors in mediating the nucleus submedius opioid-evoked antiallodynia in a neuropathic pain model of rats.
    Wang JY; Zhao M; Yuan YK; Fan GX; Jia H; Tang JS
    Neuroscience; 2006; 138(4):1319-27. PubMed ID: 16472929
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intracerebroventricular administration of anti-endothelin-1 IgG selectively upregulates endothelin-A and kappa opioid receptors.
    Wang X; Xu H; Rothman RB
    Neuroscience; 2004; 129(3):751-6. PubMed ID: 15541896
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The expression of delta- and kappa-opioid receptor is enhanced during intestinal inflammation in mice.
    Pol O; Palacio JR; Puig MM
    J Pharmacol Exp Ther; 2003 Aug; 306(2):455-62. PubMed ID: 12724348
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cloning, heterologous expression and pharmacological characterization of a kappa opioid receptor from the brain of the rough-skinned newt, Taricha granulosa.
    Bradford CS; Walthers EA; Searcy BT; Moore FL
    J Mol Endocrinol; 2005 Jun; 34(3):809-23. PubMed ID: 15956349
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Opioid binding in giant toad and goldfish brain.
    Brooks AI; Standifer KM; Cheng J; Ciszewska G; Pasternak GW
    Receptor; 1994; 4(1):55-62. PubMed ID: 8038707
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reversibility of opioid receptor occupancy of buprenorphine in vivo.
    Englberger W; Kögel B; Friderichs E; Strassburger W; Germann T
    Eur J Pharmacol; 2006 Mar; 534(1-3):95-102. PubMed ID: 16490191
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chronic ethanol modulates delta and mu-opioid receptor expression in rat CNS: immunohistochemical analysis with quantitiative confocal microscopy.
    Saland LC; Hastings CM; Abeyta A; Chavez JB
    Neurosci Lett; 2005 Jun 10-17; 381(1-2):163-8. PubMed ID: 15882810
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Opioid pharmacology.
    Trescot AM; Datta S; Lee M; Hansen H
    Pain Physician; 2008 Mar; 11(2 Suppl):S133-53. PubMed ID: 18443637
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Brain opioid receptor adaptation and expression after prenatal exposure to buprenorphine.
    Belcheva MM; Bohn LM; Ho MT; Johnson FE; Yanai J; Barron S; Coscia CJ
    Brain Res Dev Brain Res; 1998 Nov; 111(1):35-42. PubMed ID: 9804882
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of gonadal hormones on opioid receptor protein density in arthritic rats.
    Kren MC; Haller VL; Welch SP
    Eur J Pharmacol; 2008 Jan; 578(2-3):177-84. PubMed ID: 18054782
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetic variation in the behavioral effects of buprenorphine in female mice derived from a murine model of the OPRM1 A118G polymorphism.
    Browne CA; Erickson RL; Blendy JA; Lucki I
    Neuropharmacology; 2017 May; 117():401-407. PubMed ID: 28188737
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of kappa opioid receptor agonists on attention as assessed by a 5-choice serial reaction time task in rats.
    Shannon HE; Eberle EL; Mitch CH; McKinzie DL; Statnick MA
    Neuropharmacology; 2007 Dec; 53(8):930-41. PubMed ID: 17959202
    [TBL] [Abstract][Full Text] [Related]  

  • 55. JNJ-20788560 [9-(8-azabicyclo[3.2.1]oct-3-ylidene)-9H-xanthene-3-carboxylic acid diethylamide], a selective delta opioid receptor agonist, is a potent and efficacious antihyperalgesic agent that does not produce respiratory depression, pharmacologic tolerance, or physical dependence.
    Codd EE; Carson JR; Colburn RW; Stone DJ; Van Besien CR; Zhang SP; Wade PR; Gallantine EL; Meert TF; Molino L; Pullan S; Razler CM; Dax SL; Flores CM
    J Pharmacol Exp Ther; 2009 Apr; 329(1):241-51. PubMed ID: 19151246
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Opioid receptor agonists enhance the phosphorylation state of Fas-associated death domain (FADD) protein in the rat brain: functional interactions with casein kinase Ialpha, Galpha(i) proteins, and ERK1/2 signaling.
    García-Fuster MJ; Ramos-Miguel A; Miralles A; García-Sevilla JA
    Neuropharmacology; 2008 Oct; 55(5):886-99. PubMed ID: 18657552
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differential down- and up-regulation of rat brain opioid receptor types and subtypes by buprenorphine.
    Belcheva MM; Barg J; McHale RJ; Dawn S; Ho MT; Ignatova E; Coscia CJ
    Mol Pharmacol; 1993 Jul; 44(1):173-9. PubMed ID: 8393519
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of constitutive deletion of opioid receptors on the basal densities of Fas and Fas-associated protein with death domain (FADD) in the mouse brain: a delta-opioid tone inhibits FADD.
    García-Fuster MJ; Ferrer-Alcón M; Martín M; Kieffer BL; Maldonado R; García-Sevilla JA
    Eur Neuropsychopharmacol; 2007 Apr; 17(5):366-74. PubMed ID: 17030115
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acute and chronic fentanyl administration causes hyperalgesia independently of opioid receptor activity in mice.
    Waxman AR; Arout C; Caldwell M; Dahan A; Kest B
    Neurosci Lett; 2009 Oct; 462(1):68-72. PubMed ID: 19559072
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enhancement of spinal N-methyl-D-aspartate receptor function by remifentanil action at delta-opioid receptors as a mechanism for acute opioid-induced hyperalgesia or tolerance.
    Zhao M; Joo DT
    Anesthesiology; 2008 Aug; 109(2):308-17. PubMed ID: 18648240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.